{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Proventil%C2%AE+MDI&page=2", "query": { "intervention": "Proventil® MDI", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Proventil%C2%AE+MDI&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T06:04:40.743Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02210806", "title": "Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "A006 DPI", "type": "DRUG" }, { "name": "Placebo DPI", "type": "OTHER" }, { "name": "Proventil® MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 22, "start_date": "2014-07", "completion_date": "2014-10", "has_results": false, "last_update_posted_date": "2017-04-19", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 4, "location_summary": "San Jose, California • Medford, Oregon • New Braunfels, Texas + 1 more", "locations": [ { "city": "San Jose", "state": "California" }, { "city": "Medford", "state": "Oregon" }, { "city": "New Braunfels", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02210806" }, { "nct_id": "NCT00400153", "title": "Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Atrovent Respimat (20 mcg)", "type": "DRUG" }, { "name": "COMBIVENT MDI (36/206 mcg)", "type": "DRUG" }, { "name": "Combivent Respimat (20 mcg/100 mcg)", "type": "DRUG" }, { "name": "Placebo via corresponding inhaler for blinding purposes", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1480, "start_date": "2006-11", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-13", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 87, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Mobile, Alabama + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00400153" }, { "nct_id": "NCT03364608", "title": "Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "AS MDI 90 μg", "type": "DRUG" }, { "name": "AS MDI 180 µg", "type": "DRUG" }, { "name": "Placebo MDI", "type": "OTHER" }, { "name": "Proventil 90 μg", "type": "DRUG" }, { "name": "Proventil 180 μg", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 86, "start_date": "2017-12-15", "completion_date": "2018-03-30", "has_results": true, "last_update_posted_date": "2019-07-24", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 10, "location_summary": "Rolling Hills Estates, California • Stockton, California • Winter Park, Florida + 7 more", "locations": [ { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Winter Park", "state": "Florida" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03364608" }, { "nct_id": "NCT04848662", "title": "To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "BDA MDI (PT027) 160/180 μg", "type": "DRUG" }, { "name": "Pulmicort Respules 0.5 MG/ML Inhalation Suspension", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bond Avillion 2 Development LP", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "8 Years", "sex": "ALL", "summary": "4 Years to 8 Years" }, "enrollment_count": 12, "start_date": "2021-05-06", "completion_date": "2021-07-08", "has_results": true, "last_update_posted_date": "2022-05-11", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 2, "location_summary": "Oklahoma City, Oklahoma • Boerne, Texas", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Boerne", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04848662" }, { "nct_id": "NCT02513160", "title": "Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Beclomethasone Dipropionate 640", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Beclomethasone dipropionate via 320 mcg BAI", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" }, { "name": "Beclomethasone dipropionate via 320 mcg MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 713, "start_date": "2015-09-30", "completion_date": "2016-03-31", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 75, "location_summary": "Peoria, Arizona • Downey, California • Huntington Beach, California + 59 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Downey", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02513160" }, { "nct_id": "NCT00605891", "title": "Dose Finding Study of CHF 4226 for Treating Patients With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "carmoterol (CHF 4226)", "type": "DRUG" }, { "name": "salmeterol", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chiesi Farmaceutici S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 278, "start_date": "2006-10", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2017-04-11", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 24, "location_summary": "Jonesboro, Arkansas • Fresno, California • San Diego, California + 19 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00605891" }, { "nct_id": "NCT02271334", "title": "Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "A006 DPI", "type": "DRUG" }, { "name": "Proventil® MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 22, "start_date": "2014-08", "completion_date": "2015-03", "has_results": false, "last_update_posted_date": "2017-04-19", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02271334" }, { "nct_id": "NCT02040766", "title": "A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Beclomethasone dipropionate BAI", "type": "DRUG" }, { "name": "Placebo BAI", "type": "DRUG" }, { "name": "albuterol/salbutamol 90 mcg", "type": "DRUG" }, { "name": "Beclomethasone dipropionate MDI", "type": "DRUG" }, { "name": "Placebo MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 628, "start_date": "2013-12", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 75, "location_summary": "Hoover, Alabama • Montgomery, Alabama • Phoenix, Arizona + 62 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02040766" }, { "nct_id": "NCT03371459", "title": "Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "AS MDI", "type": "DRUG" }, { "name": "Proventil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 46, "start_date": "2017-12-29", "completion_date": "2018-03-26", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 5, "location_summary": "Winter Park, Florida • North Dartmouth, Massachusetts • St Louis, Missouri + 2 more", "locations": [ { "city": "Winter Park", "state": "Florida" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03371459" }, { "nct_id": "NCT01747629", "title": "Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo MDPI", "type": "DRUG" }, { "name": "Albuterol MDPI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 160, "start_date": "2012-12", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-06-26", "last_synced_at": "2026-09-28T06:04:40.743Z", "location_count": 35, "location_summary": "Costa Mesa, California • Encinitas, California • Huntington Beach, California + 30 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Palmdale", "state": "California" }, { "city": "Rancho Mirage", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01747629" } ] }